Alteration of cortical EEG in mice carrying mutated human APP transgene

Brain Research

Volumn 943, Issue 2, 2002, Pages 181-190

  Wang, Jun ^a   Ikonen, Sami ^a   Gurevicius, Kestutis ^a   Van Groen, Thomas ^a   Tanila, Heikki ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Amyloid precursor protein; EEG; Presenilin; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

AGE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCORTICOGRAPHY; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; GENE MUTATION; GENOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SOLUBILITY; TRANSGENE; TRANSGENIC MOUSE;

ACTION POTENTIALS; AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; GENOTYPE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NEURONS; PEPTIDE FRAGMENTS; PRESENILIN-1; SENILE PLAQUES;

EID: 0037067796     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02617-3     Document Type: Article

References (33)

1. Bogdanov N.N., Bogdanov M.B. The role of 5-HT1A serotonin and D2 dopamine receptors in buspirone effects on cortical electrical activity in rats. Neurosci. Lett. 177:1994;1-4.
2. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.). 82:1991;239-259.
4. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000;975-979.
5. Emilien G. Effect of drugs acting on monoaminergic and cholinergic systems on the quantified EEG of rats. Neuropsychobiology. 21:1989;205-215.
6. Foote S.L., Berridge C.W., Adams L.M., Pineda J.A. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog. Brain Res. 88:1991;521-532.
7. Gordon M.N., King D.L., Diamond D.M., Jantzen P.T., Boyett K.V., Hope C.E., Hatcher J.M., DiCarlo G., Gottschall W.P., Morgan D., Arendash G.W. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol. Aging. 22:2001;377-385.
8. Hardy J. The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc. Natl. Acad. Sci. USA. 94:1997;2095-2097.
9. Herning R.I., Glover B.J., Koeppl B., Phillips R.L., London E.D. Cocaine-induced increases in EEG alpha and beta activity: evidence for reduced cortical processing. Neuropsychopharmacology. 11:1994;1-9.
10. Herz A. Uber die Wirking von Scopolamin und ähnlichen Substanzen auf bedingte Reaktionen. Arch. Exp. Pathol. Pharmakol. 236:1959;110-112.
11. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
12. Liu L., Ikonen S., Heikkinen T., Tapiola T., van Groen T., Tanila T. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Exp. Neurol. 173:2002;196-204.
13. Longo V.G. Effects of scopolamine and atropine on electroencephalographic and behavioral reactions due to hypothalamic stimulation. J. Pharmac. 116:1966;198-208.
14. Maloney K.J., Cape E.G., Gotman J., Jones B.E. High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat. Neuroscience. 76:1997;541-555.
15. Montaron M.F., Bouyer J.J., Rougeul A., Buser P. Ventral mesencephalic tegmentum (VMT) controls electrocortical beta rhythms and associated attentive behaviour in the cat. Behav. Brain Res. 6:1982;129-145.
16. Nickel B., Szelenyi I. Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam. Neuropharmacology. 28:1989;799-803.
17. Penttilä M., Partanen J.V., Soininen H., Riekkinen P.J. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 60:1985;1-6.
18. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 4:1978;273-277.
19. Price D.L., Sisodia S.S., Gandy S.E. Amyloid beta amyloidosis in Alzheimer's disease. Curr. Opin. Neurol. 8:1995;268-274.
20. Puoliväli J., Pradier L., Riekkinen P. Jr. Moderate cortical EEG changes in apolipoprotein E-deficient mice during ageing and scopolamine treatment but not after nucleus basalis lesion. Psychopharmacol. (Berl.). 145:1999;386-392.
21. Reinikainen K.J., Riekkinen P.J., Paljärvi L., Soininen H., Helkala E.L., Jolkkonen J., Laakso M. Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem. Res. 13:1988;135-146.
22. Rice D.M., Buchsbaum M.S., Starr A., Auslander L., Hagman J., Evans W.J. Abnormal EEG slow activity in left temporal areas in senile dementia of the Alzheimer type. J. Gerontol. 45:1990;M145-151.
23. Riekkinen P., Buzsaki G., Riekkinen P. Jr., Soininen H., Partanen J. The cholinergic system and EEG slow waves. Electroencephalogr. Clin. Neurophysiol. 78:1991;89-96.
24. Riekkinen P. Jr., Sirviö J., Riekkinen P. Relationship between the cortical choline acetyltransferase content and EEG delta-power. Neurosci. Res. 8:1990;12-20.
25. Soininen H., Partanen J., Laulumaa V., Pääkkönen A., Helkala E.L., Riekkinen P.J. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr. Clin. Neurophysiol. 79:1991;342-348.
26. Soininen H., Reinikainen K.J., Partanen J., Helkala E.L., Paljärvi L., Riekkinen P.J. Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease. Neuroscience. 49:1992;529-535.
27. Steriade M., Datta S., Pare D., Oakson G., Curro Dossi R.C. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci. 10:1990;2541-2559.
28. Stigsby B., Johannesson G., Ingvar D.H. Regional EEG analysis and regional cerebral blood flow in Alzheimer's and Pick's diseases. Electroencephalogr. Clin. Neurophysiol. 51:1981;537-547.
29. L. Liu, S. Ikonen, T. Heikkinen, M. Heikkilä, J. Puoliväli, T. van Groen, H. Tanila, Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 mice, Behav. Brain Res., in press.
30. Urata J., Uchiyama M., Iyo M., Enomoto T., Hayakawa T., Tomiyama M., Nakajima T., Sasaki H., Shirakawa S., Wada K., Fukui S., Yamadera H., Okawa M. Effects of a small dose of triazolam on P300 and resting EEG. Psychopharmacol. (Berl.). 125:1996;179-184.
31. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
32. Wong T.P., Debeir T., Duff K., Cuello A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19:1999;2706-2716.
33. Wrobel A. Beta activity: a carrier for visual attention. Acta Neurobiol. Exp. (Warsz). 60:2000;247-260.